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ABSTRACT 23 
 24 
The lactate or gas exchange threshold (GET) and the critical power (CP) are closely 25 
associated with human exercise performance. We tested the hypothesis that the limit of 26 
tolerance (Tlim) during cycle exercise performed within the exercise intensity domains 27 
demarcated by GET and CP is linked to discrete muscle metabolic and neuromuscular 28 
responses. Eleven males performed a ramp incremental exercise test, 4-5 severe-intensity 29 
(SEV; >CP) constant-work-rate (CWR) tests until Tlim, a heavy-intensity (HVY; <CP but 30 
>GET) CWR test until Tlim, and a moderate-intensity (MOD; <GET) CWR test until Tlim. 31 
Muscle biopsies revealed that a similar (P>0.05) muscle metabolic milieu (i.e., low pH and 32 
[PCr] and high [lactate]) was attained at Tlim (~2-14 min) for all SEV exercise bouts. The 33 
muscle metabolic perturbation was greater at Tlim following SEV compared to HVY, and also 34 
following SEV and HVY compared to MOD (all P<0.05). The normalised M-wave 35 
amplitude for the m. vastus lateralis (VL) decreased to a similar extent following SEV (-36 
38±15%), HVY (-68 ± 24%), and MOD (-53±29%), (P>0.05). Neural drive to the VL 37 
increased during SEV (4±4%; P<0.05) but did not change during HVY or MOD (P>0.05). 38 
During SEV and HVY, but not MOD, the rates of change in M-wave amplitude and neural 39 
drive were correlated with changes in muscle metabolic ([PCr], [lactate]) and blood 40 
ionic/acid-base status ([lactate], [K
+
]) (P<0.05). The results of this study indicate that the 41 
metabolic and neuromuscular determinants of fatigue development differ according to the 42 
intensity domain in which the exercise is performed. 43 
  44 
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NEW AND NOTEWORTHY 45 
 46 
The gas exchange threshold and the critical power demarcate discrete exercise intensity 47 
domains. For the first time, we show that the limit of tolerance during whole-body exercise 48 
within these domains is characterized by distinct metabolic and neuromuscular responses. 49 
Fatigue development during exercise >CP is associated with the attainment of consistent 50 
'limiting' values of muscle metabolites whereas substrate availability and limitations to 51 
muscle activation may constrain performance at lower intensities. 52 
 53 
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INTRODUCTION 60 
 61 
Intense and/or prolonged excitation of muscle leads to a reversible decline in its force 62 
generating capacity and rate of contraction, commonly known as fatigue (21, 22, 23, 55, 27). 63 
This temporary reduction in muscle performance may be attributed to central factors that 64 
limit the neural drive for muscle contraction, and to peripheral factors, which occur at, or 65 
distal to, the neuromuscular junction and that often involve metabolic and ionic perturbations 66 
that reduce the muscle’s ability to respond to neural stimulation (2, 3, 25, 30,  41).  67 
 68 
The extent of the muscle metabolic and ionic, and blood acid-base and respiratory 69 
perturbations experienced during exercise is dependent on the exercise intensity, which can 70 
be categorised into three distinct domains demarcated by physiological thresholds (32, 72). 71 
The upper limit of the ‘moderate’ exercise intensity domain is indicated by the lactate 72 
threshold (LT; which is often estimated using the gas exchange threshold (GET)), and the 73 
boundary between the ‘heavy’ and ‘severe’ exercise intensity domains is given by the critical 74 
power (CP). Using 
31
P-magnetic resonance spectroscopy (
31
P-MRS), it has been 75 
demonstrated that severe-intensity, single-leg knee-extension exercise is associated with a 76 
progressive loss of muscle homeostasis with time (i.e. progressive reductions in muscle 77 
phosphocreatine concentration ([PCr]) and pH and an increase in inorganic phosphate 78 
concentration ([Pi])) (9, 31, 33, 69). In contrast, heavy- and moderate-intensity, small muscle 79 
mass exercise is associated with much more limited muscle metabolic perturbation with new 80 
‘steady-state’ values of [PCr], pH and [Pi] being achieved within a few minutes of the 81 
initiation of exercise (33, 48, 67). These intensity-related differences in muscle metabolic, as 82 
well as related blood acid-base and respiratory gas exchange, responses to exercise (33, 51, 83 
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68, 73) likely underpin the close relationships reported between these threshold phenomena 84 
(LT/GET and CP) and human exercise performance (8).     85 
 86 
The role of exercise intensity in defining the extent and dynamics of muscle metabolic 87 
perturbation implies that exercise intensity may also influence the nature of neuromuscular 88 
fatigue development (3, 22, 24, 39, 41, 52, 53). The peripheral component to fatigue, as 89 
estimated non-invasively using surface electromyography (EMG), electrical muscle 90 
stimulation and/or transcranial magnetic stimulation, appears to be especially important 91 
during high-intensity exercise (45, 64, 66), whereas central fatigue may be more prominent 92 
during prolonged, low-intensity exercise (38, 45, 57, 61, 66). The intensity-dependent 93 
interaction between peripheral and central components of fatigue is thought to be modulated 94 
by changes in afferent feedback arising from the muscle metabolic milieu. Consistent with 95 
this, the critical torque (CT; analogous with the CP) for small muscle mass exercise has been 96 
shown to represent a threshold in the development of neuromuscular fatigue (10), such that 97 
severe-intensity knee-extensor contractions (>CT) were associated with elevated motor unit 98 
recruitment and a disproportionate increase in the rate of neuromuscular fatigue development 99 
relative to heavy-intensity contractions (<CT).  100 
 101 
It is presently unclear whether the determinants of neuromuscular fatigue development during 102 
whole-body exercise, such as cycling, differ according to the intensity domain in which 103 
exercise is performed. Previous studies have assessed neuromuscular fatigue before and after 104 
self-paced maximal time trial cycle exercise (66) and during constant-work-rate (CWR) 105 
cycling performed ostensibly within the severe-intensity domain (65). These studies 106 
suggested that, in contrast to knee extension exercise (10), the level of peripheral fatigue at 107 
exhaustion for cycling may also be intensity-dependent above CP (65). Compared to small 108 
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muscle mass exercise, whole-body exercise is associated with greater rates of pulmonary 109 
ventilation and gas exchange (58, 74), differences in cardiac output and muscle perfusion (12, 110 
46, 58), and greater activity of type III/IV muscle afferents that may modulate central drive 111 
(52, 53). It is possible that these factors impact the relationship between muscle metabolic 112 
changes and neuromuscular fatigue development during exercise. 113 
 114 
To date, the physiological and neuromuscular responses to whole-body exercise, and their 115 
possible inter-relationship, has not been assessed within distinct exercise intensity domains. 116 
The purpose of this study was therefore to evaluate possible differences in the muscle 117 
metabolic and systemic responses to different, well-defined, intensities of exercise, with the 118 
aim of elucidating whether the exercise intensity domain influences the determinants of 119 
neuromuscular fatigue. Based on earlier studies investigating small muscle mass exercise (33, 120 
69), we tested the hypotheses that: 1) a consistent muscle metabolic milieu ([ATP], [PCr], 121 
[lactate], pH) and neuromuscular responses (muscle excitability and neural drive) will be 122 
attained at the limit of tolerance (Tlim) during severe-intensity exercise (>CP); 2) severe-123 
intensity exercise will be associated with greater muscle metabolic perturbation compared to 124 
heavy- and moderate-intensity exercise; and 3) the rate of neuromuscular fatigue 125 
development will be greater during severe- compared to heavy- and moderate-intensity 126 
exercise due to greater muscle metabolic and ionic perturbations. 127 
 128 
METHODS 129 
 130 
Ethical approval 131 
The protocols were approved by the host institution’s Research Ethics Committee and 132 
conducted in accordance with the code of the ethical principles of the World Medical 133 
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Association (Declaration of Helsinki). Subjects gave written informed consent to participate 134 
after the experimental procedures, associated risks, and potential benefits of participation had 135 
been explained. 136 
 137 
Subjects 138 
Eleven healthy recreationally active males (mean ± SD: age 21.8 ± 1.9 years, height 1.79 ± 139 
0.05 m, body mass 78.2 ± 8.1 kg) volunteered to participate in this study, 8 of whom 140 
volunteered to provide muscle tissue samples. One of the subjects who volunteered for the 141 
biopsy procedure withdrew from the study having completed only the severe-intensity 142 
exercise trials. This subject’s data were excluded from statistical difference tests, but included 143 
in the correlational analysis. All subjects were in good health and had no known history of 144 
neurological or motor disorder. Subjects were instructed to report to all testing sessions in a 145 
rested and fully hydrated state, ≥3 h post-prandial, and to avoid strenuous exercise and refrain 146 
from caffeine and alcohol in the 24 h prior to testing. Each subject started each experimental 147 
trial at the same time of day (±2 h). All trials were performed on the same electronically-148 
braked cycle ergometer (Lode, Excalibur, Groningen, The Netherlands).  149 
 150 
Experimental design 151 
Each subject visited the laboratory on ~7 occasions over a 6-wk period with each visit 152 
separated by a minimum of 24 h. A minimum of 7 days recovery was provided following the 153 
heavy- and moderate-intensity exercise tests. After the completion of a ramp incremental test 154 
(visit 1), subjects performed 4-5 CWR severe-intensity exercise tests to define the power-155 
duration relationship, a heavy-intensity CWR test and a moderate-intensity CWR test, 156 
completed in a randomised order (Figure 1) except that the severe-intensity tests always 157 
preceded the heavy-intensity test. Pulmonary gas exchange was measured continuously 158 
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during all tests, with the exception of the moderate-intensity test in which it was measured 159 
periodically for 10 min intervals, with the mid-point of collection coinciding with blood 160 
sample collection and femoral nerve stimulation (see below). We encouraged the subjects to 161 
continue exercising during the moderate-intensity test to enable 10 min of gas exchange data 162 
to be collected immediately prior to exercise cessation. EMG data were obtained 163 
continuously from m. vastus lateralis (VL) and m. vastus medialis (VM) throughout the 164 
exercise period with stimulation of the femoral nerve delivered at regular intervals (Figure 1) 165 
to quantify the neuromuscular changes occurring during the exercise protocols. Venous blood 166 
samples were obtained before and during exercise for the moderate-, heavy-, and for three of 167 
the severe-intensity exercise tests. In addition, muscle tissue was obtained at rest, and 168 
immediately following the moderate-, heavy-, and three of the severe-intensity exercise tests 169 
(Figure 1). The severe-intensity tests were performed at 3-5 different work-rates (spanning 170 
60%Δ to O2peak; (where Δ refers to the work-rate difference between the GET and the 171 
O2peak). Three of these severe-intensity tests (including short 85 ± 5%Δ, intermediate 75 ± 172 
5%Δ, and long 65 ± 5%Δ) were grouped and compared to test for differences in muscle, 173 
neuromuscular, and blood responses within the severe-intensity domain. 174 
 175 
Incremental test 176 
On the first laboratory visit, subjects completed a ramp incremental test for the determination 177 
of the O2peak and gas exchange threshold (GET). The ergometer seat height and handlebars 178 
were adjusted for comfort and the same settings were replicated for each subsequent test. 179 
Initially, subjects completed 3 min of baseline cycling at 20 W, after which the work-rate was 180 
increased by 30 W∙min-1 until volitional exhaustion. The subjects cycled at a constant self-181 
selected pedal rate (80 rpm, n = 9, 90 rpm, n = 2), which was recorded and reproduced in 182 
subsequent tests. The test was terminated when the pedal rate fell more than 10 rpm below 183 
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the preferred value for more than 5 s despite strong verbal encouragement. Breath-by-breath 184 
pulmonary gas exchange data were collected continuously throughout the test and recorded as 185 
10-s moving average for data analysis. O2peak was determined as the highest mean O2 186 
during any 30-s period and the GET was determined as previously described (5, 68).  187 
 188 
CWR tests 189 
All CWR tests started with 3 min of cycling at 20 W, followed by a step increase to the 190 
required work-rate. Subjects were instructed to remain seated and to maintain their preferred 191 
pedal rate for as long as possible. Strong verbal encouragement was provided, but subjects 192 
were not informed of either the work-rate or the elapsed time. The tests were terminated 193 
when pedal rate fell more than 10 rpm below the preferred value for more than 5 s. The Tlim 194 
was recorded to the nearest second.  195 
 196 
The parameters of the power-duration relationship (CP and W′) were estimated by 197 
completion of 4-5 severe-intensity exercise tests (4 trials, n = 9; 5 trials n = 2) at different 198 
work-rates (approximately 60%Δ, 70%Δ, 80%Δ and 100% O2peak) resulting in Tlim ranging 199 
between approximately 2 and 14 min. If the standard errors associated with the CP and W′ 200 
exceeded 5 and 10 %, respectively, after four exercise tests had been completed, a fifth test 201 
was performed. Any tests in which the end-exercise O2 was <95% of the individual’s ramp 202 
test determined O2peak were excluded from the modelling of the power-duration 203 
relationship.  204 
 205 
The CP and W′ (the amount of work done above the CP) parameters were estimated using 206 
three models: the hyperbolic P-Tlim model (Equation 1); the linear work-time (W-Tlim) model, 207 
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where the total work done (W) is plotted against time (Equation 2); and the linear inverse-of-208 
time (1/Tlim) model, where power output is plotted against the inverse of time (Equation 3): 209 
 210 
Tlim = W′ / (P – CP)          [1] 211 
W = CP · Tlim + W′          [2] 212 
P = W′ (1/ Tlim) + CP          [3] 213 
 214 
The standard errors of the estimate associated with the CP and W′ were expressed as 215 
coefficients of variation (CV%, i.e. relative to the parameter estimate). For each individual, 216 
the ‘best fit’ model associated with the lowest CV% for CP and Wʹ was used for further 217 
analyses (7). 218 
 219 
The work-rate for the heavy-intensity CWR trial was equal to the lower bound of the 95% 220 
confidence limit in the CP parameter (33). The moderate-intensity CWR trial was performed 221 
at a work-rate corresponding to 90% of the GET. Subjects were permitted to ingest water ad 222 
libitum during the heavy- and moderate-intensity tests. 223 
 224 
Pulmonary gas exchange 225 
Breath-by-breath pulmonary gas exchange and ventilation were measured continuously 226 
during all exercise tests, with the exception of the moderate-intensity test, where it was 227 
measured at discrete time points (Figure 1). Subjects wore a nose clip and breathed through a 228 
mouthpiece and impeller turbine assembly (Jaeger Triple V, Jaeger, Hoechberg, Germany). 229 
The inspired and expired gas volume and concentration signals were continuously sampled at 230 
100 Hz (Oxycon Pro, Jaeger, Hoechberg, Germany) via a capillary line connected to the 231 
mouthpiece. The gas analysers were calibrated before each trial with gases of known 232 
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concentration and the turbine volume transducer was calibrated using a 3-L syringe (Hans 233 
Rudolph, Kansas City, MO). The volume and concentration signals were time aligned by 234 
accounting for the delay in capillary gas transit and the analyser rise time relative to the 235 
volume signal.  236 
 237 
Blood analyses 238 
Venous blood samples were drawn into 5-mL heparinised syringes (Terumo Corporation, 239 
Leuven, Belgium) from a cannula (Insyte-W™, Becton-Dickinson, Madrid, Spain) inserted 240 
into the subject’s antecubital vein. The blood was analysed for [lactate] and [glucose] within 241 
~5 min of collection (YSI 2300, Yellow Springs Instruments, Yellow Springs, OH). The 242 
remaining whole blood was then centrifuged at 4,000 rpm for 7 min (Hettich EBA 20, 243 
Germany) before plasma was extracted and analysed for [K
+
] (9180 Electrolyte Analyser, F. 244 
Hoffman-La Roche, Basel, Switzerland).  245 
 246 
Neuromuscular Function 247 
EMG was used to continuously record the VL and VM activity during exercise, using active 248 
bipolar bar electrodes with single differential configuration (DE2.1, DelSys Inc, Boston, MA, 249 
USA), positioned over the muscle belly (SENIAM guidelines). The ground electrode was 250 
positioned on the patella. Double-sided adhesive interfaces and hypoallergenic medical tape 251 
were used to keep the EMG sensors in place and to reduce skin impedance. The leads 252 
connected to the electrodes were secured using hypoallergenic medical tape to minimise 253 
artefacts due to movement of the leads. The skin area underneath each electrode was shaved, 254 
abraded, and cleaned with alcohol swabs prior to electrode placement to minimise skin 255 
impedance. The EMG signal was considered of good quality when the average rectified EMG 256 
baseline level for each muscle was below 2 μV (18). The EMG signals were pre-amplified 257 
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(1,000x), band-pass filtered (20-450 Hz, Bagnioli-8, DelSys Inc, Boston, MA), and digitised 258 
at a sampling rate of 2,000 Hz and resolution of 16 bits using a Power 1401 mk-II analog-to-259 
digital converter and Spike 2 data collection software run by custom written sampling 260 
configuration (CED, Cambridge Electronic Design, UK).   261 
 262 
The location of the optimal site for transcutaneous femoral nerve stimulation was determined 263 
whilst the subject was positioned on the cycle ergometer. Using an adhesive cathode (Boots 264 
UK Ltd, Nottingham, England) placed approximately 2 cm medial of the femoral pulse, and 265 
an adhesive anode (Boots UK Ltd, Nottingham, England) placed at the anterior aspect of the 266 
iliac crest, single electrical pulses generated by a constant current stimulator (DS7 A, 267 
Digitimer Ltd, UK) were delivered. The cathode was systematically moved vertically and 268 
horizontally and the amplitude of the compound muscle action potential (CMAP, M-wave) 269 
was monitored to identify the optimal position of the cathode for attaining maximal peak-to-270 
peak M-wave amplitude during the cycling trials. 271 
 272 
Following the attachment of the EMG and the stimulation electrodes, the crank angle at 273 
which stimulation was to be delivered during the trials was determined for each subject. The 274 
subject was positioned on the cycle ergometer and cycled at a moderate work-rate (20 W 275 
below GET) for 1 min. The EMG activity obtained during this period was rectified and 276 
averaged for 20 complete crank revolutions. The duration of each revolution was determined 277 
by a custom-made magnetic switch that generated an event marker signal on each occasion 278 
that the crank passed top dead centre (i.e. 0º). For each subject, the crank angle at which the 279 
rectified VL EMG activity was maximal was determined, and as performed by Sidhu et al 280 
(56) stimulations were delivered at the identified crank angle for all subsequent trials for that 281 
participant (65 ± 5° relative to the top dead centre). A custom written sequencer script 282 
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triggered 3 stimulations, with at least 1 and up to 10 pedal revolutions between stimuli. The 283 
intervals were randomly determined using a random number generator incorporated within 284 
the sequencer script. This was designed to prevent participants from anticipating the stimulus 285 
delivery, which may affect the evoked response. 286 
 287 
A standard M-wave recruitment curve protocol was completed during each laboratory visit. 288 
The subject cycled at 20 W below GET throughout the recruitment curve protocol. A single-289 
pulse electrical stimulation (200 µs) was delivered at the individually identified crank angle 290 
as described above. The current was increased in 20 mA increments until the M-wave 291 
amplitude plateaued at the maximal M-wave amplitude (Mmax). A pulse of 130% Mmax 292 
current was applied during the exercise tests (mean stimulation intensity: 350 ± 50 mA). 293 
 294 
The EMG signals from the VL and VM were processed using a custom written script to 295 
measure peak-to-peak M-wave amplitude and M-wave area. The root-mean-square (RMS) of 296 
the EMG signal (an index of the power of the signal) was calculated as the mean over a 25 297 
ms pre-stimulation period at each stimulation time point. The EMG RMS amplitudes and the 298 
M-wave parameters were normalised to the corresponding values attained after 1 min of 299 
exercise during each trial to evaluate temporal changes in the voluntary muscle activation 300 
level (i.e. the EMG RMS amplitude) and the peripheral neuromuscular excitability (i.e. the 301 
M-wave amplitude and area). In addition, the voluntary EMG RMS amplitude was 302 
normalised to the M-wave amplitude recorded at that time point to assess changes in neural 303 
drive (RMS/M; 42). The rates of change in M-wave and EMG parameters from baseline 304 
cycling to Tlim were calculated for each exercise to quantify the rate of neuromuscular fatigue 305 
development in each intensity domain. 306 
 307 
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Muscle biopsy 308 
The biopsy site was prepared on the alternate thigh to the EMG and peripheral nerve 309 
stimulation setup. Local anaesthesia was applied (2-3 ml of 20 mg.ml
-1
 lidocaine) and an 310 
incision was made in the medial region of the VL. Muscle samples were obtained using 311 
needle biopsy with suction (6). Resting muscle samples were obtained prior to any exercise 312 
on the first laboratory visit and post-exercise biopsies were taken within ~10 s of the 313 
cessation of each exercise test with the subject supported on the ergometer. The muscle tissue 314 
was rapidly frozen in liquid nitrogen.  315 
 316 
Muscle tissue analysis 317 
The frozen muscle samples from each biopsy were weighed before and after freeze-drying to 318 
determine water content. After freeze-drying, the muscle samples were dissected free from 319 
blood, fat and connective tissue. Prior to muscle metabolite analysis, 200 µl of 3 M perchloric 320 
acid was added to approximately 2.5 mg d.w. muscle. The solution was then centrifuged and 321 
placed on ice for 30 min. It was subsequently neutralised to pH 7.0 with 255 µl of cooled 322 
potassium bicarbonate (KHCO3) and centrifuged (10,000 g). The supernatant was analysed 323 
for PCr, ATP and lactate by fluorometric assays (35). An aliquot containing 1-2 mg d.w. 324 
muscle was extracted in 1 M hydrochloric acid (HCl) and hydrolysed at 100ºC for 3 h before 325 
glycogen content was determined using the hexokinase method (35). Muscle pH was 326 
measured using a glass electrode following the homogenisation of 1-2 mg d.w. of muscle in a 327 
non-buffering solution containing 145 mM KCl, 10 mM NaCl and 5 mM iodoacetic acid. 328 
 329 
Statistical analyses 330 
One-way ANOVAs with repeated measures were used to assess differences between severe-331 
intensity exercise tests in O2peak, muscle [ATP], [PCr], [pH], [lactate], and [glycogen], M-332 
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wave amplitude, M-wave area, voluntary EMG amplitude and RMS/M, and blood and 333 
plasma variables at Tlim. The data from the severe-intensity tests were subsequently averaged 334 
for each individual for comparison with the heavy- and moderate-intensity tests. Differences 335 
in O2peak, muscle [ATP], [PCr], [pH], [lactate], and [glycogen] between the severe-, heavy- 336 
and moderate-intensity tests were assessed using one-way ANOVAs. Two-way repeated 337 
measures ANOVAs (condition x time) were used to analyse differences in M-wave amplitude 338 
and area, and voluntary EMG amplitude for the VL and VM, and blood and plasma variables 339 
at common time-points (baseline, 1 min, 3 min and Tlim) among the severe-, heavy-, and 340 
moderate-intensity tests. Significant interaction and main effects were followed up with 341 
Bonferroni post-hocs. Relationships between the rates of change of metabolic and 342 
neuromuscular variables were assessed using Pearson’s product-moment correlation 343 
coefficients. Statistical significance was set at P<0.05 and data are presented as mean ± SD.  344 
 345 
RESULTS 346 
 347 
The O2peak measured in the ramp incremental test was 4.32 ± 0.46 L∙min
-1 (56 ± 8 mL∙kg-348 
1∙min-1) and the peak work-rate was 385 ± 50 W. The GET occurred at 2.33 ± 0.34 L∙min-1 349 
and 137 ± 24 W. 350 
 351 
Physiological responses within the severe-intensity domain 352 
The Tlim in the severe-intensity CWR exercise tests ranged from 2.2 to 13.9 min. There were 353 
no differences between the three models (Equations 1-3) in the CP or W′ estimates (P>0.05; 354 
Table 1). The CP from the best fit model corresponded to 64 ± 7% of ramp test peak work-355 
rate and 45 ± 11%Δ.  356 
 357 
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The O2peak during the shorter (~85%Δ: 4.43 ± 0.50 L∙min
-1), intermediate (~75%Δ: 4.49 ± 358 
0.47 L∙min-1) and longer (~65%Δ:  4.41 ± 0.47 L∙min-1) severe-intensity tests were not 359 
different from the O2peak achieved during the ramp incremental test (all P>0.05). 360 
Moreover, no significant differences were observed at Tlim among the three severe-intensity 361 
tests for any of the muscle tissue variables or for blood [lactate] (all P>0.05; Figure 2). There 362 
were also no differences in plasma [K
+
] at Tlim among the shorter (5.6 ± 0.6 mM), 363 
intermediate (5.8 ± 1.1 mM,) and longer (5.7 ± 0.6 mM) severe-intensity tests (P>0.05). 364 
 365 
Physiological responses during severe-, heavy- and moderate-intensity exercise 366 
Pulmonary O2, blood [lactate] and plasma [K
+
] during moderate-, heavy- and severe-367 
intensity exercise are illustrated in Figure 3. The Tlim for heavy-intensity exercise (231 ± 56 368 
W) was 43.5 ± 16.2 min (range: 20.5 to 67.4 min) and the O2 at Tlim (3.78 ± 0.53 L∙min
-1 
; 369 
87 ± 4% of O2peak) was lower than the ramp test O2peak (P<0.05). The Tlim for the 370 
moderate-intensity exercise (113 ± 19 W) was 211.1 ± 57.0 min (range: 180 to 360 min) and 371 
the O2 at Tlim (2.22 ± 0.38 L∙min
-1
, 52 ± 8% of O2peak) was not different from the GET 372 
(P>0.05).  In 9 out of 11 subjects the O2 remained below the GET throughout the moderate 373 
exercise bout. 374 
 375 
During severe-intensity exercise, blood [lactate] increased rapidly until Tlim and was 376 
significantly greater than baseline after 3 min (P<0.05). During heavy-intensity exercise, the 377 
rate of blood [lactate] increase was slower than during severe-intensity exercise such that 378 
blood [lactate] did not differ from baseline until after 10 min (P<0.05), and no further 379 
increase was observed between 10 min and Tlim (P>0.05) (Figure 3B). Plasma [K
+
] was 380 
elevated above baseline at all measurement time points during heavy- and severe-intensity 381 
exercise (all P<0.05). The [K
+
] continued to rise throughout severe-intensity exercise, 382 
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whereas it stabilised during heavy-intensity exercise beyond 6 min (Figure 3C). During 383 
moderate-intensity exercise, blood [lactate] did not change from baseline (P>0.05) while 384 
plasma [K
+
] was elevated above resting baseline at 1 min (P<0.05), with no further increase 385 
thereafter (all time points P>0.05).  386 
 387 
Muscle metabolic variables at rest and at Tlim following moderate-, heavy- and severe-388 
intensity exercise are illustrated in Figure 4. For severe- and heavy-intensity exercise, muscle 389 
[ATP], [PCr] and pH were lower and muscle [lactate] was greater at Tlim relative to rest (all 390 
P<0.05). There was no significant muscle [glycogen] depletion during severe-intensity 391 
exercise relative to rest (P>0.05) but there was a tendency for glycogen depletion during 392 
heavy-intensity exercise (P=0.06).  In contrast, for moderate-intensity exercise, muscle [PCr] 393 
at Tlim was greater than for severe- and heavy-intensity exercise (all P<0.05), and muscle 394 
[glycogen] was both lower than at rest and lower than at Tlim for heavy- and severe-intensity 395 
exercise (all P<0.05). Muscle [pH] and [lactate] did not change significantly from rest during 396 
moderate-intensity exercise (P>0.05).  397 
 398 
Neuromuscular responses during severe-, heavy- and moderate-intensity exercise 399 
The coefficients of variation (CV%) between trials during unloaded cycling were 25% (VL) 400 
and 35% (VM) for the peak-to-peak M-wave amplitude, and 32% (VL) and 32% (VM) for 401 
the M-wave total area. The CV% between stimulations during unloaded cycling was 11% 402 
(VL) and 9% (VM) for the peak-to-peak M-wave amplitude and 10% (VL) and 9% (VM) for 403 
the M-wave total area. The mean Mmax amplitudes measured during cycling at 20 W below 404 
GET (VL 2.77 ± 1.43 and VM 0.99±1.18 mV) were not different between visits (all P>0.05). 405 
No significant differences were observed between trials in the neural drive to VL and VM 406 
during cycling at 20 W below GET. 407 
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 408 
Neuromuscular excitability: M-wave amplitude and M-wave area 409 
The M-wave characteristics at Tlim for the three severe-intensity exercise tests, and for 410 
moderate-intensity, heavy-intensity and the mean of the severe-intensity exercise tests are 411 
shown in Figure 5A-D. Peripheral neuromuscular excitability at Tlim, indicated by the M-412 
wave amplitude and M-wave area, did not differ among the severe-intensity tests (all P<0.05) 413 
(Figure 5A, C). The M-wave amplitude and M-wave area at Tlim were greater for severe-414 
intensity exercise compared to both heavy- and moderate-intensity exercise in the VM 415 
(P<0.05), and the M-wave area at Tlim was also greater in severe- than in heavy-intensity 416 
exercise in VL (P<0.05) (Figure 5B, D). Differences in M-wave characteristics between 417 
severe-, heavy- and moderate-intensity exercise at each measurement time point are shown in 418 
Figure 6A-D. 419 
 420 
Voluntary activation and neural drive 421 
Voluntary muscle activation level, measured as EMG RMS amplitude, and neural drive, as 422 
indicated by RMS/M-wave amplitude, did not differ at Tlim among the severe-intensity 423 
exercise tests (all P<0.05) (Figure 5E, G). Both EMG RMS and RMS/M were greater at Tlim 424 
for severe-intensity compared to heavy- and moderate-intensity exercise in the VM (P<0.05) 425 
(Figure 5F). In the VL, the EMG RMS at Tlim was also greater for severe- than for heavy-426 
intensity exercise and the RMS/M was greater for severe- than for moderate-intensity 427 
exercise (both P<0.05) (Figure 5F, H). The only difference in neuromuscular variables 428 
observed at Tlim between moderate- and heavy-intensity exercise was a significantly greater 429 
EMG RMS in the VL (Figure 5F). Differences in EMG RMS and RMS/M severe-, heavy- 430 
and moderate-intensity exercise at each measurement time point are shown in Figure 6E-H. 431 
 432 
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Relationships between physiological and neuromuscular variables 433 
During severe-intensity exercise, the M-wave amplitude decreased in parallel with [PCr] 434 
depletion and plasma K
+
 accumulation (Table 2). Moreover, increased neural drive (RMS/M) 435 
was correlated with high blood [lactate] and plasma [K
+
], and to low muscle [PCr], and high 436 
muscle [lactate] and [glycogen] (Table 2). During heavy-intensity exercise, the reduction in 437 
M-wave amplitude was related to low muscle [PCr] and high plasma [K
+
], and increased 438 
neural drive was related to high plasma [K
+
] and low muscle [PCr], and high muscle [lactate] 439 
and [glycogen] (Table 2). During moderate-intensity exercise, the M-wave amplitude was 440 
inversely correlated with the reduction in [PCr] (Table 2). 441 
 442 
DISCUSSION 443 
 444 
To our knowledge, the present study is the first to combine muscle biopsy, blood analyses 445 
and measurements of neuromuscular excitability and neural drive (via electrical stimulation 446 
of the femoral nerve during exercise) to assess the muscle metabolic, acid-base and 447 
neuromuscular responses to cycling performed within discrete exercise intensity domains 448 
(32). The data presented herein provide novel insight into the in vivo relationships between 449 
exercise intensity, muscle metabolic perturbation and neuromuscular function and support the 450 
notion that LT/GET and CP separate exercise intensity domains within which exercise 451 
tolerance is limited by discrete fatigue mechanisms. In classical terms, when exercise 452 
intensity exceeds CP, the oxidation of fat and carbohydrate cannot keep pace with required 453 
ATP turnover and the rate of pyruvate production from glycolysis exceeds the capacity of the 454 
Krebs cycle, resulting in progressive increase in intramuscular lactate and H
+
 concentrations. 455 
We demonstrated that a similar muscle metabolic milieu (i.e., [ATP], [PCr], [lactate] and pH) 456 
was attained at Tlim irrespective of work-rate within the severe-intensity domain. The muscle 457 
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metabolic perturbation was greater (i.e., lower [ATP] and pH, and higher [lactate]) at Tlim 458 
following severe- compared to heavy-intensity exercise, and also following severe- and 459 
heavy- compared to moderate-intensity exercise. In contrast, more extensive muscle glycogen 460 
depletion occurred during moderate- compared to both severe- and heavy-intensity exercise.  461 
 462 
However, while the results indicate that CP represents a critical threshold for both muscle 463 
metabolic control and neuromuscular fatigue development, the importance of the GET in 464 
separating exercise intensity domains was less obvious; unlike some muscle metabolic, 465 
pulmonary gas exchange and blood [lactate] responses, neuromuscular indices of fatigue 466 
development were not strikingly different between moderate-intensity and heavy-intensity 467 
exercise. 468 
 469 
Fatigue during severe-intensity exercise 470 
The Tlim during the severe-intensity exercise tests ranged from 2.2 min to 13.9 min and in all 471 
cases, subjects achieved O2peak. Historically, the amount of work that can be done above 472 
CP (i.e., the curvature constant of the power-duration relationship, W′), and therefore the 473 
cause(s) of exercise intolerance within the severe-intensity domain, has been linked to the 474 
depletion of the high-energy phosphates and a source related to anaerobic glycolysis, along 475 
with a finite amount of stored O2 (43,44). Consistent with this, recent studies have 476 
demonstrated that, at least for small muscle mass exercise, the utilisation of this finite energy 477 
store (W′) coincides with the depletion of muscle PCr and the accumulation of fatigue-related 478 
metabolites (i.e. Pi, H
+
) until a consistent, presumably ‘limiting’ value is attained (33, 69). 479 
The findings of the current study indicate that, irrespective of work-rate or exercise duration 480 
(~2-14 min), Tlim during severe-intensity exercise is associated with the attainment of 481 
consistently low values of muscle [PCr] (~23% of resting value), [ATP] (~76% of resting 482 
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value) and pH (~6.56), and consistently high values of muscle [lactate] (~1382% of resting 483 
value), as well as blood [lactate] (~838% of resting value). It should be noted that the 484 
observed muscle metabolite and substrate changes are reflective of the homogenate muscle 485 
sample and therefore reflect the mean values for that particular muscle portion. It is known 486 
that the depletion of muscle [PCr] during exercise displays significant regional heterogeneity 487 
(13, 54). It is therefore possible that the subjects’ eventual failure to maintain the requisite 488 
power output was caused by the attainment of sufficiently low values of [PCr] and, perhaps, 489 
[ATP], and/or sufficiently high values of muscle metabolites ([Pi], [ADP], [H
+
] and their 490 
sequelae) within some of the recruited muscle fibres (51; see also 3,23, 24). Clearly, subjects 491 
either could not, or would not, tolerate this ‘critical combination’ of substrate and metabolite 492 
concentrations, but it is not possible to ascertain whether this was related to direct effects of 493 
the muscle metabolic milieu on contractile function (17) or to the attainment of some 494 
individual sensory ‘critical fatigue threshold’ which might constrain central motor drive and 495 
muscle activation via feedback from type III/IV neural afferents (4). The appreciable 496 
metabolic perturbation we observed during severe-intensity exercise was associated with a 497 
concomitant decrease in M-wave amplitude in both the VL and VM. A strong inverse 498 
correlation was observed between both the voluntary EMG RMS amplitude and neural drive, 499 
and the changes in [ATP] and [PCr] (Table 2). This is consistent with there being greater 500 
engagement of central neural mechanisms (e.g. muscle fibre recruitment and firing frequency 501 
modulation) in order to compensate for peripheral fatigue development.  502 
 503 
We have proposed that the changes in muscle metabolic status that occur concomitantly with 504 
the expenditure of the Wʹ are driving the development of the O2 slow component during 505 
severe-intensity exercise (8, 33, 70). Thus, exercise intolerance in this intensity domain is 506 
associated with the complete utilisation of W′, the attainment of some ‘critical’ combination 507 
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of muscle substrate and/or metabolite concentrations, and the achievement of O2peak (8, 14, 508 
47, 70). In the present study, we observed a reduction in muscle excitability in parallel with 509 
the increased metabolic stress. The reduction in muscle membrane excitability is likely 510 
mediated, at least in part, by changes in plasma [K
+
] (Table 2), which may reflect a rise in 511 
interstitial [K
+
] within the t-tubule weakening propagation of the action potential along the 512 
surface membrane. Increased extracellular [K
+
] impairs force generation due to 513 
depolarisation of the cell membrane, resulting in a reduced amplitude of the action potential 514 
(11, 40). This process attenuates Ca
2+
 release from the sarcoplasmic reticulum, reducing 515 
cross-bridge formation and the force generating capacity of the myocyte (36). In our study, 516 
the increased plasma [K
+
] was accompanied by a transient increase in neural drive which was 517 
brought about via a preservation of the EMG amplitude with reduced M-wave amplitude. It 518 
was notable that the reductions in M-wave amplitude and M-wave area in the VM during 519 
exhaustive severe exercise were less pronounced compared to moderate and heavy exercise 520 
(Figure 5 B and D), suggesting that the muscle excitability was preserved to a greater extent 521 
than at lower exercise intensities. It is important, however, to consider this finding in the 522 
context of increasing neural drive during severe exercise (Figure 6 G and H) which implies 523 
that exercise cessation was not due to central fatigue.  Low muscle pH attained during severe 524 
exercise may attenuate the reduction in muscle membrane excitability (3, 24). Furthermore, 525 
the muscle glycogen content, a key regulator of sarcoplasmic Ca
2+
 release rate and thus 526 
muscle excitability (15, 50), did not fall significantly during severe exercise. Precisely how 527 
the utilisation of the Wʹ, the associated alterations in muscle substrate and metabolite 528 
concentrations, and ionic changes influence muscle excitability warrants further 529 
investigation. 530 
 531 
Fatigue during heavy-intensity exercise 532 
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Heavy-intensity exercise was maintained for an average of 43.5 min (Tlim ranged from 20.5 to 533 
67.4 min) and, in contrast to severe-intensity exercise, no subject achieved O2peak at Tlim 534 
(~87% O2peak). Consistent with our second hypothesis, the muscle metabolic perturbation 535 
experienced following heavy-intensity exercise was less than that observed following severe-536 
intensity exercise, but was greater than that observed following moderate-intensity exercise. 537 
At Tlim, significant reductions were observed in muscle [PCr] (~66%), [ATP] (~12%), [pH] 538 
(~97%]) and [glycogen] (~59%), and there was a significant increase in muscle [lactate] 539 
(~447%) relative to resting values. Similarly, blood [lactate] and plasma [K
+
] displayed 540 
greater perturbation relative to moderate-intensity exercise, but less perturbation relative to 541 
severe-intensity exercise (Figure 3). It is of interest that the decrease in muscle excitability 542 
from rest to Tlim was greater during heavy-intensity than during severe-intensity exercise 543 
(Figure 5). Following the onset of exercise, plasma [K
+
] increased rapidly to attain a peak 544 
value at 10 min which was sustained until Tlim; the reduction in M-wave amplitude followed 545 
a similar temporal profile. It is therefore likely that the initial reduction in M-wave amplitude 546 
was a result of plasma [K
+
] accumulation which reduced the release of Ca
2+
 from the 547 
sarcoplasmic reticulum, impairing excitation-contraction coupling (36, 71). As heavy-548 
intensity exercise continued, it is possible that the combined metabolic and ionic perturbation, 549 
coupled with the ~60% decrease in muscle [glycogen], may have further impaired Ca
2+
 550 
release and cross-bridge formation (2, 3, 23, 24, 36, 40, 41) and/or the sensitivity of the 551 
myofilaments to Ca
2+
 (17). Although more complicated than for severe-intensity exercise, 552 
fatigue development during heavy-intensity exercise appears to be related to the combined 553 
influence of ionic changes on muscle membrane excitability, muscle metabolite 554 
accumulation, and the decrease in energy substrate, which act collectively to impair 555 
excitation-contraction coupling. 556 
 557 
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Fatigue during moderate-intensity exercise 558 
Moderate-intensity exercise, performed at a work-rate of 20 W below the GET, was 559 
continued for an average of 211 min with subjects working at ~52% O2peak at Tlim. Muscle 560 
metabolic perturbation was relatively slight in this domain (Figure 3). For example, at the end 561 
of exercise, muscle [PCr] had fallen to ~76% of the baseline value and pH had fallen by 0.1 562 
unit from the resting value, while blood [lactate] and plasma [K
+
] were also largely 563 
unchanged (Figures 3 and 4). There was, however, a large reduction (–83%) in muscle 564 
[glycogen] (1, 29, 59, 60). It is therefore likely that the development of peripheral fatigue 565 
within the moderate-intensity domain is related to the depletion of muscle glycogen and 566 
impairment in neuromuscular excitability and transmission (15, 28, 49, 50, 62). In addition to 567 
being an essential substrate for the regeneration of ATP, it has been demonstrated that under 568 
conditions where [ATP] is held high, that low muscle [glycogen] can impair muscle function 569 
(49, 62). The association between low muscle [glycogen] and impaired muscle function can 570 
be attributed to glycogen’s modulatory role in the release of Ca2+ from the sarcoplasmic 571 
reticulum (15, 19, 20, 28, 49, 50). In keeping with glycogen’s role in excitation-contraction 572 
coupling, individuals deficient in glycogen phosphorylase (McArdle’s disease) do not 573 
experience a considerable fall in pH but demonstrate an earlier decline in the M-wave 574 
amplitude during exercise (16). Furthermore, glucose administration during exercise has been 575 
shown to partially restore both the M-wave amplitude and muscle contractility (34, 37, 63) 576 
supporting the notion that carbohydrate availability modulates muscle excitability and 577 
contractile function. The findings of the present study show that moderate-intensity exercise 578 
(<GET) can be sustained for a long duration with little change in muscle metabolites and 579 
indicate that muscle glycogen depletion is the likely mechanism responsible for the decline in 580 
neuromuscular function and exercise intolerance in this domain. 581 
 582 
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The majority of research investigating neuromuscular fatigue development during exercise 583 
has focused on small muscle groups and has been limited to the assessment of neuromuscular 584 
function pre-exercise and as soon as possible (usually within 2-3 minutes) post-exercise. 585 
Considering the task-specific nature of neuromuscular fatigue development, and the rapid 586 
recovery in muscle function (within 2 min) after high-intensity cycle exercise (26), it is 587 
possible that the previously reported changes in neuromuscular function pre- to post-exercise 588 
underestimate fatigue development during exercise. Recently, Sidhu et al. (56) adopted an 589 
approach that uses the motor compound action potential (M-wave) for the assessment of 590 
changes in neuromuscular function during cycle exercise. Adopting a similar approach to 591 
Sidhu et al. (56), we found large reductions in the M-wave amplitude and M-wave area in 592 
both the VL and VM during exercise to Tlim in each discrete exercise intensity domain. This 593 
suggests that changes in muscle excitability linked to the fatigue process can occur 594 
consequent to a wide range of perturbations in muscle and blood chemistry, with limited 595 
differentiation between exercise intensity domains. The consistency of indices of 596 
neuromuscular fatigue during severe-intensity cycling exercise in our study contrasts with a 597 
recent report of Thomas et al. (65) in which peripheral fatigue, assessed post-exercise using 598 
electrical stimulation during isometric contractions, was greater at higher work-rates within 599 
the severe-intensity domain. It is possible that this reflects differences in the experimental 600 
techniques employed, and underlines the importance of accounting for the task-specificity of 601 
fatigue and the dynamics of muscle recovery post-exercise (10).    602 
 603 
Conclusion 604 
This study employed a novel and rather comprehensive combination of invasive and non-605 
invasive techniques that enabled simultaneous assessment of metabolic, ionic, systemic and 606 
neuromuscular factors that define muscular performance. Although direct measures of the 607 
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contribution of central factors to fatigue were not employed, peripheral nerve stimulation permitted 608 
elucidation of their relative importance in neuromuscular fatigue development during 609 
exhaustive cycle exercise performed within each of the well-defined exercise intensity 610 
domains. This study is consistent with the notion that the GET and the CP demarcate exercise 611 
intensity domains within which fatigue is mediated by distinct mechanisms. Exercise 612 
intolerance within the severe-intensity domain (>CP) was associated with the attainment of a 613 
consistent critical muscle metabolic milieu (i.e., low [PCr] and pH and high [Pi]). In contrast, 614 
moderate-intensity exercise (<GET) was associated with more significant depletion of muscle 615 
[glycogen]. The cause(s) of fatigue during heavy-intensity exercise (>GET, <CP) was/were 616 
more obscure with intermediate changes in muscle metabolic perturbation and glycogen 617 
depletion being apparent. These results are consistent with the notion that both the GET and 618 
CP demarcate exercise intensity domains characterised by distinct respiratory and metabolic 619 
profiles. Strikingly, CP represents a boundary above which both metabolic and 620 
neuromuscular responses conform to a consistent ceiling or nadir irrespective of work-rate 621 
and exercise duration.  622 
623 
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Figure Legends 899 
 900 
Table 1 The CP and Wʹ parameter estimates derived from Equations 1-3 and the ‘best fit’ 901 
model. 902 
 903 
Table 2 The correlation coefficients between the rate of change in blood and muscle tissue 904 
variables and the rate of change in neuromuscular variables measured in m. vastus lateralis. * 905 
P<0.05. 906 
 907 
Figure 1. Schematic of the exercise protocol. Group mean work-rates are shown for the 908 
severe- (solid line), heavy- (dotted line) and moderate- (dashed line) intensity trials. All trials 909 
were started with a 3-min “warm-up” phase at 20 W, followed by an immediate “step” 910 
increase to the required work-rate. Subjects were encouraged to continue exercising for as 911 
long as possible. The dashed arrows indicate the collection of venous blood, and femoral 912 
nerve stimulation. The solid arrows indicate the collection of muscle tissue. N.B., for clarity, 913 
the resting muscle sample obtained prior to the first trial is not shown.      914 
Figure 2. Muscle metabolic responses ([ATP] panel A, [PCr] panel B, pH panel C, [lactate] 915 
panel D, [glycogen] panel E) and blood [lactate] (panel F) at Tlim were not different following 916 
exhaustive exercise at three different severe-intensity work-rates. R = rest; S1 = short trials at 917 
~85%Δ (Tlim = 224 ± 41 s); S2 = intermediate trials at ~75%Δ (Tlim = 333 ± 131 s); and S3 = 918 
long trials at ~65%Δ (Tlim = 475 ± 145 s). * Different from S1, S2 and S3 (P<0.05). 919 
Figure 3. Pulmonary O2 (panel A), blood [lactate], (panel B) and plasma [K
+
] (panel C) 920 
response to severe- (solid circle), heavy- (clear circle) and moderate- (solid triangle) intensity 921 
40 
 
exercise. To aid clarity error bars have been omitted from all but the final data point.  a = 922 
different from moderate-intensity P<0.05; b = different from heavy-intensity P<0.05. 923 
 924 
Figure 4. Muscle [ATP] (panel A), [PCr] (panel B), [pH] (panel C), [lactate] (panel D), and 925 
[glycogen] (panel E) at rest (white triangle), and following severe- (black circle), heavy- 926 
(white circle), and moderate-intensity exercise (black triangle). * = different from rest 927 
P<0.05; a = different from moderate-intensity P<0.05; b = different from heavy-intensity 928 
P<0.05; c = different from severe-intensity P<0.05. 929 
 930 
Figure 5. The group mean ± SD M-wave amplitude and M-wave area (normalised to  931 
maximum  M-wave during baseline pedalling) indicating peripheral neuromuscular 932 
excitability (panels A-D); voluntary EMG RMS amplitude (normalised to M-wave amplitude 933 
at 1 min of exercise) indicating muscle activation level (panels E and F); and RMS/M-wave 934 
(normalised to corresponding M-wave amplitude at each measurement time point) indicating 935 
central fatigue (panels G and H) at the limit of tolerance (Tlim) for moderate-, heavy- and 936 
severe-intensity exercise (panels B, D, F, H) and for three work-rates (severe 1 ~85%Δ, 937 
severe 2 ~75%Δ and severe 3 ~65%Δ) within the severe-intensity domain (panels A, C, E, 938 
G). There were no significant differences among the severe-intensity work-rates in muscle 939 
excitability (A, C) or in indices of central fatigue (E, G). VL = m. vastus lateralis; VM = m. 940 
vastus medialis; EMG = electromyogram; RMS = root mean square; a = different from 941 
moderate-intensity P<0.05; b = different from heavy-intensity P<0.05; c = different from 942 
severe-intensity P<0.05. 943 
 944 
Figure 6. The normalised M-wave amplitude (panels A and B), M-wave area (panels C and 945 
D), voluntary EMG RMS amplitude (panels E and F), and RMS/M-wave amplitude (panels G 946 
41 
 
and H) during severe- (solid circle), heavy- (clear circle), and moderate-intensity (solid 947 
triangle) exercise in m. vastus lateralis (VL) and vastus medialis (VM). M-wave amplitude 948 
and area were normalised to maximum M-wave during baseline pedalling, EMG RMS was 949 
normalised to M-wave amplitude at 1 min of exercise, and RMS/M-wave was normalised to 950 
corresponding M-wave amplitude at each measurement time point. Error bars have been 951 
omitted from all but the final data point to aid clarity. 
a
 Different from rest; 
b
 different from 952 
severe-intensity (P<0.05); 
c
 different from heavy-intensity (P<0.05); 
d
 different from 953 
moderate-intensity (P<0.05); and 
e
 trend for difference from heavy-intensity (P=0.055). 954 
 955 
  956 
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Table 1 The parameter estimates derived from Equations 1-3 and the ‘optimised fit’ model. 
 
 
 R
2
 CP (W) SEE (W) CV% W’ (kJ) SEE (kJ) CV% 
W-Tlim model 0.993 – 1.000 253 ± 54 6 ± 3 2.6 ± 1.4 22.5 ± 5.3 2.3 ± 1.0 11.0 ± 6.2 
1/Tlim model 0.939 – 0.999 252 ± 52 7 ± 4 3.0 ± 2.3 20.7 ± 5.2 1.9 ± 1.1 9.5 ± 5.6 
P-Tlim model 0.919 – 1.000 248 ± 52  5 ± 3 2.2 ± 1.4 22.4 ± 3.8 2.5 ± 1.8 11.3 ± 9.4 
Optimised fit model 0.944 – 1.000 250 ± 53 5 ± 2 2.0 ± 1.2 22.5 ± 6.1 1.8 ± 0.8 8.3 ± 4.5 
43 
 
 
Table 2. The correlation coefficients between the rate of change in blood and muscle tissue 
variables and the rate of change in neuromuscular variables measured in m. vastus lateralis. * 
P<0.05.  
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